Related Experiment Video
Updated: May 13, 2026
08:51
Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla
Published on: February 19, 2021
LSN MS guidelines for the management of multiple sclerosis
A R Shatila1, S Koussa, R Jabbour
1Neurology Division Makassed Hospital, Ouzai Street Tarik Al-Jadida, Beirut, Lebanon.
Revue Neurologique
|February 26, 2013
Summary
Guidelines for diagnosing and managing multiple sclerosis (MS) in Lebanon were established, addressing regional differences. Future research on MS epidemiology and treatment in Lebanon was also recommended.
Area of Science:
- Neurology
- Epidemiology
Background:
- The prevalence of multiple sclerosis (MS) in Lebanon is not well-documented.
- Middle Eastern countries have unique diagnostic and management considerations for MS compared to Western nations.
Purpose of the Study:
- To establish consensus-based guidelines for MS diagnosis, treatment, follow-up, and management specific to Lebanon.
- To foster future research collaborations on MS epidemiology, clinical trials, and fundamental aspects within Lebanon.
Main Methods:
- A committee of neurologists, under the Lebanese Society of Neurology (LSN), convened to develop consensus recommendations.
- The committee operated under the supervision of a LSN-appointed coordinator.
Main Results:
- Recommendations were formulated for diagnosis, therapy, follow-up, and research, tailored to Lebanon's specific context.
- Emphasis was placed on identifying high-risk individuals, optimizing therapeutic opportunities, cost-effective treatment monitoring, and comprehensive disability assessment.
Conclusions:
- Consensus guidelines for the diagnosis, treatment, and follow-up of MS patients in Lebanon were successfully established.
- Recommendations for future clinical and fundamental research projects were proposed.
Related Concept Videos
01:19Multiple Sclerosis l: Introduction
Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
01:23Atherosclerosis IV: Nursing Management
Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...
01:24Nephrotic Syndrome III : Nursing Management
Nursing management for nephrotic syndrome adapts as the disease progresses, with strategies evolving to address advancing symptoms and complications.Early-Stage Management In the early stages, nursing interventions for nephrotic syndrome resemble those used in managing acute glomerulonephritis, focusing on symptom monitoring, fluid balance, and managing mild to moderate edema.Vital Signs: Regularly monitor blood pressure, pulse, respiratory rate, and temperature to promptly identify...
01:26Peripheral Artery Disease IV: Nursing Management
The nursing management of a patient with peripheral artery disease (PAD) begins with a thorough assessment of the patient’s health history and clinical manifestations.AssessmentHealth History: Evaluate the patient’s history of hypertension, hyperlipidemia, family history of cardiovascular issues, and lifestyle factors such as dietary patterns, smoking, and physical activity.Physical Examination:Assess the affected extremity for decreased or absent peripheral pulses, temperature changes,...
01:20Myasthenia Gravis: Overview and Treatment
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
01:22Myocarditis IV: Nursing Management
Myocarditis is an inflammatory condition of the myocardium requiring meticulous nursing management for optimal patient outcomes. Effective management begins with a thorough assessment of the patient's medical history, paying close attention to past infections, autoimmune disorders, travel history, and exposure to toxins or drugs. Recent viral infections and systemic diseases are particularly relevant due to their potential role in triggering myocarditis.Physical Examination and MonitoringThe...